Antiviral medications may be used in COVID-19 patient:s at increased risk for severe disease progression.1, 2 The antiviral PAXLOVID® (nirmatrelvir [PF-07321332] / ritonavir) is the only oral COVID-19 therapy approved and recommended in Switzerland.2-4 The five-day treatment can be dispensed by all pharmacies on prescription and by self-dispensing physicians directly and should be used as soon as possible after a positive viral test for SARS-CoV-2.1-3
This content is machine-translated. Please contact us if you need professional translation services.
Partner
Related Topics
You May Also Like
- Cardiac arrhythmias
Atrial fibrillation – what do current guidelines say?
- PANCREATIC CELLS
Exploration map
- DIABETES AND OBESITY
Influence of movement and muscle regulation
- New studies on COPD
From inhalers, allergies and physical activity
- Rare diseases
The Alagille syndrome
- Interventional valve therapy
Gender differences
- The future is near or here?
Ablation for atrial fibrillation
- Anemia